Delivery Order SPE2D020D0009-SPE2D325F6852

Award Date 2/24/25
Potential Completion Date 2/27/25
Potential Value $3.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division was issued to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The $14,225.60 firm-fixed-price delivery order contract is for the supply of calcium gluconate injection, a critical care medication used in military medical facilities worldwide. The contract has an ultimate completion date of June 28, 2024. Fresenius Kabi holds a significant indefinite delivery contract (IDV)...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract is for the supply of calcium gluconate injection, a medication used for calcium deficiency and other medical conditions. The contract has a ceiling value of $1,422.56 and a period of performance through April 8, 2024. No set-aside was used for this procurement. The contract is likely...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This federal contract award, SPE2D020D0009|SPE2D321F127A, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $91,849.42 firm fixed-price delivery order is for the supply of Doxycycline Hydrochloride Injection (10), a critical care pharmaceutical product. Fresenius Kabi has an Indefinite Delivery Contract (IDV) valued at $2.24 million with the Department of...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The $443,723.27 contract is for the delivery of injectable drugs, intravenous solutions, and other pharmaceutical products. This order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a government-wide acquisition vehicle managed by the Department of Veterans Affairs. The contract does...
This federal contract award is for the delivery of Doxycycline Hydrochloride Injection (10) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a delivery order with a firm fixed price of $22,035.23 and a completion date of September 27, 2024. There is no set-aside designation associated with this contract. Fresenius Kabi, LLC...
This federal contract award, valued at $8,517.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care pharmaceutical product, with a completion date of September 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Fresenius Kabi, LLC is...
This federal contract award, SPE2D020D0009|SPE2D325F6837, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Lidocaine Hydrochloride Injection USP 25, a critical care pharmaceutical product, with an ultimate completion date of February 27, 2025. The contract is a firm fixed-price delivery order with a ceiling value of $1,947.33. The...
This is a delivery order under contract SPM2D012D0007 | SPE2D019F0052, awarded to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The $1,248,732.76 firm-fixed-price contract is for the delivery of various injectable drugs, intravenous solutions, and other pharmaceutical products to the Department of Defense's Medical Supply Chain. The contract does not have a set-aside designation. Fresenius Kabi USA, LLC is a major supplier of essential medical supplies and...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D325F6852
    Delivery Order

This federal contract award, SPE2D020D0009|SPE2D325F6852, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $3,632.58 firm fixed-price delivery order is for the supply of Calcium Gluconate Injection USP 100mg/mL 10mL, a critical care pharmaceutical. This order is not associated with a set-aside program. Fresenius Kabi, LLC holds a significant Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs National Acquisition Center, valued at $2,237,072.60, for the supply of Bortezomib vials, a cancer treatment drug, to various federal healthcare systems. This contract award highlights Fresenius Kabi's role as a key vendor in the federal medical supply chain, providing a diverse range of essential injectable pharmaceuticals to military and government facilities nationwide.

Generated 6/1/25, 3:13 AM